We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy.
Research, Translational Medicine, Press Releases
Antibody signatures are found to predict treatment success for two leading checkpoint inhibitors.
September 15, 2022
Patient Care, In the Media, Translational Medicine
Dr. David J. Byun says the role and optimal duration of hormone therapy continue to remain controversial.
September 12, 2022
Dr. Ruth Oratz says that while the study results are exciting, more research needs to be done.
Dr. Maya Dimitrova says tumor-infiltrating lymphocyte therapy could expand available melanoma treatments.
September 10, 2022
The combination of olaparib and bevacizumab represents a new standard of care, Dr. Eva Chalas says.
September 9, 2022
Patient Care, Translational Medicine, Press Releases
Dr. Oren Cahlon has been appointed senior vice president and deputy chief clinical officer.
September 7, 2022
Dr. Elisabeth J. Cohen is enhancing the department’s longstanding commitment to research.
Together, psilocybin and psychotherapy reduced alcohol consumption by 83 percent among heavy drinkers.
August 24, 2022
Research, Patient Care, Translational Medicine
Dr. Elaine Shum is leading this trial, which aims to fill an unmet need for targeted therapies.
July 27, 2022
Patient Care, Translational Medicine
Joining the Experimental Therapeutics Clinical Trials Network advances cancer clinical trial capabilities.
July 21, 2022
We can help you find a doctor. Call 646-929-7800 or browse our specialists.